In the Press: The Hollywood Reporter
Forget Psychedelics, Everyone’s microdosing Ozempic now
In a recent interview with The Hollywood Reporter, I discussed the growing trend of microdosing Ozempic, a medication originally designed for type 2 diabetes management, now being used off-label in smaller doses for weight loss and other health benefits.
I shared insights into how individuals are exploring this approach to mitigate side effects and reduce costs associated with full dosages.
While some anecdotal evidence suggests positive outcomes, I emphasized the importance of consulting healthcare professionals before considering microdosing, as it is not FDA-approved and may carry potential risks.
